EUVIMEDEUVIMED entdecken
Crossref

Australian vaccine preventable disease epidemiological review series: tetanus 2003–2019

Eliora SG Morris, Aditi Dey, Kaitlyn Vette, Harunor Rashid, Nicholas Wood, Frank Beard

Communicable Diseases Intelligence · 2023

DOI: 10.33321/cdi.2023.47.61 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Communicable Diseases Intelligence, 2023. Verfasst von Eliora SG Morris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Tetanus, Vaccine-Preventable Diseases, Diphtheria-Tetanus-acellular Pertussis Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We examined trends in tetanus notification, hospitalisation and death data from 2003–2019 to assess the impact of adult tetanus booster recommendations in Australia.

Methods

Tetanus notifications and deaths from the National Notifiable Diseases Surveillance System; hospitalisations from the Australian Institute of Health and Welfare National Hospital Morbidity Database; and deaths from the Australian Coordinating Registry were analysed by age group, sex, Aboriginal and Torres Strait Islander status and state/territory. Annual rates were calculated using Australian Bureau of Statistics mid-year estimated resident populations from 2003–2019 as denominators. To assess the impact of a recommended booster dose of reduced antigen content diphtheria–tetanus–acellular pertussis (dTpa) vaccine for adults aged ≥ 65 years, notification, hospitalisation and death rates of tetanus per 100,000 population were compared pre (2003–2012) and post (2013–2019) the recommendation’s introduction.

Results

There were 63 notifications of tetanus from 2003–2019 with an average annual incidence rate of 0.02/100,000. Similar to previous studies, the burden of tetanus in the Australian population continues to disproportionately affect the elderly, with those aged ≥ 65 years encompassing 63% (40/63) of notifications and 100% (11/11) of the deaths observed in this timeframe. Following the introduction of a recommendation for those aged ≥ 65 years to receive a dTpa booster, average annual notification and hospitalisation rates in those aged ≥ 65 years were significantly lower (notifications: 0.11/100,000 in 2003–2012 and 0.05/100,000 in 2013–2019, p = 0.01; hospitalisations: 0.24/100,000 in 2003–2012 and 0.10/100,000 in 2013–2019, p = 0.01]). The average annual death rate was similar in the two periods (0.002/100,000), although based on small numbers.

Conclusions

The findings of this analysis suggest a positive impact from the 2013 recommendation. However, the burden is still disproportionately higher in those aged ≥ 65 years and strategies to improve vaccination coverage in older Australians are recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TetanusVaccine-Preventable DiseasesDiphtheria-Tetanus-acellular Pertussis VaccinesAdultAgedHumansVaccinationAustraliaPentetic AcidAustralian Aboriginal and Torres Strait Islander Peoples

Stichwörter der Autor:innen

booster vaccinationepidemiologyimmunisationtetanusvaccine preventable disease

Substanzen

Diphtheria-Tetanus-acellular Pertussis VaccinesPentetic Acid

Autor:innen und Institutionen

  • Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia; National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia.
  • Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia; National Centre for Immunisation Research and Surveillance, Westmead, New South Wales, Australia. frank.beard@health.nsw.gov.au.

Zitieren

APA

Morris, E. S., Dey, A., Vette, K., Rashid, H., Wood, N., & Beard, F. (2023). Australian vaccine preventable disease epidemiological review series: tetanus 2003–2019. Communicable Diseases Intelligence. https://doi.org/10.33321/cdi.2023.47.61

Vancouver

Morris ES, Dey A, Vette K, Rashid H, Wood N, Beard F. Australian vaccine preventable disease epidemiological review series: tetanus 2003–2019. Communicable Diseases Intelligence. 2023. doi:10.33321/cdi.2023.47.61

BibTeX
@article{Morris2023,
  author = {Morris, Eliora SG and Dey, Aditi and Vette, Kaitlyn and Rashid, Harunor and Wood, Nicholas and Beard, Frank},
  title = {Australian vaccine preventable disease epidemiological review series: tetanus 2003–2019},
  journal = {Communicable Diseases Intelligence},
  year = {2023},
  doi = {10.33321/cdi.2023.47.61}
}
Kostenlos starten →